The decrease in membrane microviscosity of erythrocyte ghosts in the presence of clinically relevant concentrations of seven inhalation anaesthetic agents was studied using fluorescence polarization anisotropy of the membrane incorporated fluorescent probes 1,6-diphenyl-1,3,5-hexatriene and 1-[4-trimethylammoniumphenyl]-6-phenyl-1,3,5-hexatriene. All anaesthetic agents produced a dose-dependent decrease in anisotropy of both probes, indicating decreased membrane microviscosity. The reduction in anisotropy measured at the minimum alveolar concentration (ED 50 ) for anaesthesia was related inversely to the anaesthetic potency of the agent and was directly proportional to the hypothetical concentration of agent in the membrane calculated from lipid-water partition coefficients. These findings do not support the hypothesis that volatile anaesthetic agents act by increasing membrane microviscosity of the bulk lipid bilayer to produce anaesthesia. (Br.
The mechanism of action of inhalation anaesthetics remains unknown even though these agents are used widely in clinical practice. The anaesthetic potency of the volatile agents is correlated most closely with their solubility in non-polar solvents and lipid. [1] [2] [3] [4] [5] It has been implied from this relationship that volatile anaesthetic agents may act to alter neuronal membrane function. [3] [4] [5] This could occur either through a generalized perturbation of neuronal membrane bilayer structure, by non-specific interaction of membrane dissolved agents with bilayer lipids or by direct modification of neuronal membrane protein activity by interaction with specific hydrophobic binding sites on sensitive proteins. A variety of changes in membrane dynamic properties in the presence of volatile agents have been demonstrated by various biophysical techniques and include increased rotational motion, decreased phase transition temperature, decreased surface viscosity, weakened binding of interfacial water, volume expansion and competition of membrane hydrogen bonds (reviewed by Aloia, Curtain and Gordon 6 ). Many of these phenomena have been observed at supra-clinical anaesthetic concentrations and it remains to be determined if any of these perturbations in membrane dynamic properties are relevant to the process of anaesthesia.
The activity and kinetics of membrane-bound enzymes and carrier proteins can be markedly affected by the fluidity of the lipid phase of the membrane. 7 Several neuronal protein activities have been reported to be sensitive to the presence of volatile agents [8] [9] [10] [11] [12] [13] and some of these could be involved in the mechanism of anaesthesia. Modification of membrane dynamic properties by volatile anaesthetic agents may be sufficient to transduce the anaesthetic effect of agents in the nervous system. For example, a link between membrane lipid order and sodium channel activity has been proposed from a strong linear relationship between voltage-dependent uptake of 24 
Na
; into isolated mouse brain synaptosomes and the decrease in fluorescence polarization of membrane incorporated probes, 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-[4-trimethylammoniumphenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH).
14 By analogy, it has been suggested that changes in protein function induced by membrane dynamic changes, such as the sodium channel, perhaps in conjunction with alterations in other synaptic processes, could result in modified membrane conductance or synaptic transmission and transduce the anaesthetic effect of membrane dissolved agents. [3] [4] [5] If the primary action of the inhalation anaesthetics involves alteration of a property of the lipid bilayer to transduce the effect of agent in the membrane at a functional level, it would be predicted that when tested at equipotent concentrations for anaesthesia the volatile agents may be expected to produce the same degree of perturbation in that variable. Although not all biological membranes would be involved in transducing the anaesthetic effect, anaesthetic perturbation of membrane dynamics would be expected to be universal. To test this hypothesis, anaesthetic-induced increases in erythrocyte membrane microviscosity produced by clinically relevant concentrations of seven volatile anaesthetic agents were investigated to allow the degree of membrane perturbation at the ED 50 for anaesthesia for the agents to be determined. Probes studied were DPH, which incorporates into the core hydrophobic region of the lipid bilayer, and TMA-DPH, which localizes in the outer regions of the lipid bilayer by virtue of the cationic trimethylammornium group. 15 These probes intercalate between membrane lipid molecules and the fluorescence polarization anisotropy reports on the restriction of movement of the probe molecule and thus reflects largely the rotational movement of the probe in the membrane. The greater the polarization of the fluorescent emission in response to a polarized excitation the more restricted is the probe in the membrane. Thus fluorescent polarization anisotropy reports on the membrane microviscosity in the environs of the probe.
Materials and methods
DPH and TMA-DPH were Obtained from Molecular Probes Inc. (Eugene, Oregon, USA). Anaesthetic agents were obtained as follows: desflurane was a gift of Pharmacia (St Albans, Hertfordshire, UK), halothane and trichloroethylene were from ICI Pharmaceuticals (Macclesfield, Cheshire, UK), isoflurane and enflurane were from Abbott Laboratories Ltd (Maidenhead, Berkshire, UK), methoxyflurane was from C-Vet (Bury St Edmunds, Suffolk, UK) and nitrous oxide from BOC Ltd (Derby, Derbyshire, UK). Air and oxygen were from BOC Ltd. All other reagents used were of the highest grade available.
ERYTHROCYTE GHOST MEMBRANES
Venous blood samples were collected from 10 healthy volunteers into tubes containing ethylenediaminetetraacetic acid as anticoagulant. Plasma and the buffy coat were removed after centrifugation at 1900 x g for 10 min at 4 ЊC. Erythrocyte ghost membranes were prepared as reported previously 16 and stored at 920 ЊC until use.
MEMBRANE MICROVISCOSITY MEASUREMENTS
Erythrocyte ghost membranes, 100 g of protein ml 91 in 1 ml of Tris-HCl 10 mmol litre 91 (pH 7.4), were incubated in a thermistor-controlled water bath at 37Ϯ0.1 ЊC and volatile anaesthetic agents delivered at the required concentration from laser refractometer calibrated vaporizers (Ohmeda TEC (0-2% trichloroethylene; 1-3% methoxyflurane; 0-5% halothane; 0-4% isoflurane; 0-4% enflurane) or TEC 6 (0-20% desflurane)) via a manifold of 10 outlets, each delivering humidified air 60 ml min 91 to each sample. The deadspace over each sample was 11 ml. Carrier gas flow through the vaporizers was 2 litre min 91 and any excess gas not delivered to experimental tubes was exhausted to the atmosphere. The time taken for each agent to reach stable equilibrium in the aqueous phase was determined in preliminary experiments by following the decrease in DPH and TMA anisotropy with gas delivery at the lowest concentration of each agent to be studied until steady state anisotropy was attained (not shown). Equilibration times were confirmed at approximate MAC concentrations of agent delivered by gas chromatographic analysis using a Perkin-Elmer 8410 gas chromatograph 17 (table 1) . Volatile agents (0.2% trichloroethylene, 0.5% methoxyflurane, 0.75% halothane, 1.25% isoflurane and 1.7% enflurane) were delivered for various times (0-60 min) to samples containing 100 g of erythrocyte ghost membrane protein in 1 ml of Tris-HCl 10 mmol litre 91 (pH 7.4). Aliquots (100 l) were mixed with n-heptane 100 l (halothane, isoflurane, enflurane) or toluene 100 l (trichloroethylene, methoxyflurane) in glass vials on ice. The vials were sealed to prevent evaporation before analysis. The non-aqueous phase was injected onto a 30-m DB17 megabore column under the following conditions: injection temperature 120 ЊC; oven temperature 90 ЊC; flame ionization detector at 120 ЊC. The amount of anaesthetic in each sample was determined from the peak height against a standard curve for the agent. All experiments in which polarization anisotropy was measured were performed under steady state conditions to ensure equilibration of the anaesthetics. Pre-equilibration was for 15 min for enflurane, halothane, isoflurane and desflurane, and 60 min for methoxyflurane and trichloroethylene. Nitrous oxide was delivered with oxygen from a Boyles anaesthetic machine for 15 min. Control samples were exposed to air or oxygen only, as appropriate, for the same period.
DPH (in tetrahydrafuran) and TMA-DPH (in dimethylformamide) were added to erythrocyte ghost membranes to final concentrations of 0.5 and 5 mol litre 91 , respectively, and incubated for 30 min at 37 ЊC with gas delivery as before. Addition of solvent from the stock solution never exceeded 0.05%. Fluorescence polarization anisotropy, as a measure of the degree of depolarization of the emitted signal, was measured in duplicate at 37 ЊC using a Perkin-Elmer LS50 luminescence spectrofluorimeter. Excitation and emission wavelengths were 365 nm and 456 nm. Background fluorescence from unlabelled membrane samples, which was always less than 3% of the total signal, was subtracted from measurements in which probes were incorporated. All measurements were made in duplicate. Under vertical polarized light excitation (subscript V), fluorescence polarization anisotropy was defined by the equation: 18
Results
Maximum concentrations of agents used in this study did not alter the wavelength of emission maxima or affect the intensity of emission of membrane incorporated probes in the analyses of fluorescence spectra. We conclude that depolarization measured in the presence of anaesthetic agents was a result of membrane disruption and not alteration of fluorescence life-time by quenching. A dose-dependent decrease in the anisotropy of both DPH and TMA-DPH was observed over the clinically relevant range of concentrations studied for each agent ( fig. 1) . The shapes of the dose-response curves varied with each agent and with the distribution of the fluorophore in the membrane.
The ability of equipotent concentrations of agents to perturb membrane microviscosity was assessed by comparing the change in anisotropy of the two membrane incorporated probes at the concentration of agents that produces anaesthesia in 50% of a population, ED 50 (minimum alveolar concentration, MAC). Values for the change in anisotropy at MAC were derived from the data in figure 1. An inverse relationship between the change in anisotropy of both membrane probes at MAC and anaesthetic potency was observed ( fig. 2 Stable equilibrium between gaseous and aqueous phases at delivered gaseous concentrations of approximately 1 MAC was confirmed for five of the agents (table 1) . A theoretical concentration of agent in the erythrocyte membrane at the MAC concentration of delivered gases was calculated, 12 using olive oil-gas partition coefficients where known (unknown for desflurane), and related to the change in anisotropy at MAC for each of the agents ( fig. 3) . A linear relationship between the change in anisotropy and theoretical membrane concentration was observed for anisotropy determined with the DPH probe (correlation coefficient r:90.89, P:0.02) but when TMA-DPH was used as probe this relationship only approached statistical significance (r:90.79, P:0.06).
Discussion
The identity of the primary site(s) of action of volatile anaesthetic agents remains to be determined. There has been much discussion on whether or not an interaction in the membrane bilayer or a direct interaction with hydrophobic sites on target proteins is responsible for anaesthesia (reviewed in Aloia, Curtain and Gordon, 6 Miller, 8 Koblin 9 and Franks and Lieb 12 13 ). Polarization anisotropy of the membrane incorporated fluorescent probes DPH and TMA-DPH in the presence of clinically relevant concentrations of volatile agents suggested that decreased membrane microviscosity is linked to changes in functional properties of the membrane. 14 25 To test if there is a relationship between anaesthetic potency and the ability of volatile anaesthetic agents to produce membrane perturbation, reflected by polarization anisotropy of membrane incorporated probes, the change in anisotropy of the probes DPH and TMA-DPH was investigated in this study for a range of volatile anaesthetic agents at clinically relevant concentration ranges. The erythrocyte membrane was used as a simple model biological membrane system with a defined composition and devoid of organelle membranes of varying composition that could have complicated interpretation. Although the magnitude of changes produced in the erythrocyte membrane may be quantitatively different, this membrane system would be expected to mirror changes that occur in other membranes that may have a more direct involvement in the mechanism of anaesthesia.
Using DPH and TMA-DPH to probe the core and outer regions of the bilayer, respectively, 15 we found that clinical concentrations of all agents produced a decrease in anisotropy consistent with decreased membrane microviscosity. The different shapes of the dose-response curves for alteration of membrane microviscosity obtained both for different agents and with respect to localization of the probe in the bilayer suggested complex and non-uniform interactions of the agents within the membrane. Contrary to the proposed hypothesis that equipotent clinical concentrations of volatile anaesthetics would produce a similar degree of membrane perturbation, the most potent anaesthetic agents produced the least change in anisotropy of probes at MAC concentrations. This series of observations indicates that there is no direct relationship between the ability of an agent to alter the anisotropy of membrane probes and anaesthetic potency and argues against a role for disruption of bulk phase membrane microviscosity in the transduction of the effect(s) of volatile anaesthetic agents to membrane mechanisms. These observations further suggest that links between membrane microviscosity and membrane function identified previously 14 25 are unrelated to anaesthetic action.
Dissociation of membrane perturbing effects and anaesthetic mechanism has been suggested previously in a study comparing the actions of 
2-[2-methoxyethoxy]-ethyl
8-[cis-2-n-octylcyclopropyl]-octanoate (A 2 C) and benzyl alcohol. 26 In common with benzyl alcohol, i.v. administration of A 2 C was found to perturb brain membranes but, unlike benzyl alcohol, A 2 C did not produce either intoxication or anaesthesia in mice. Both A 2 C and benzyl alcohol were found to inhibit [ 9 uptake was proposed to be distinct from an "anaesthetic" site responsible for augmentation of 36 Cl 9 flux and anaesthesia. From the inability to detect membrane perturbations at clinically relevant concentrations of volatile agents using several biophysical techniques, [27] [28] [29] [30] it has been argued that the mechanism of anaesthesia of these agents does not involve acting as hydrophobic solutes to produce non-specific perturbation of bulk phase membrane properties and, hence, membrane protein function. Such conclusions presuppose that the chosen biophysical variable investigated reflects any membrane action of an anaesthetic, that a change in properties is observed within the time scale of the measurement and that the variable is sufficiently sensitive to demonstrate an interaction. As important as showing absence of anaesthetic effect at clinical concentrations is investigation of the significance of anaesthetic-induced membrane perturbations that have been reported at clinically relevant concentrations of volatile agents. 14 25 The inverse relationship between the ability to perturb membrane microviscosity and anaesthetic potency observed in this study suggests that links between membrane perturbation and membrane protein function reported previously 14 25 may be secondary phenomena, reflecting the presence of the anaesthetic molecules in the membrane rather than perturbations of relevance to the mechanism of anaesthesia.
As measurements were made at steady state between the gaseous and aqueous phases we were able to calculate a theoretical concentration of each agent in the lipid phase using olive oil-gas partition coefficients. Partition coefficients into lipid systems related to a phospholipid bilayer were not known for enough of the agents to allow this relationship to be calculated for a more representative lipid phase. Although partitioning of gases into olive oil and the erythrocyte membrane is unlikely to be identical, a proportionality in solubility between the two systems would be expected. Despite the differences in chemical structure between the anaesthetics, the change in anisotropy at the MAC concentration was proportional to the calculated theoretical concentration of agent in the lipid phase and, hence, the relative number of molecules of anaesthetic in the lipid bilayer. This correlation was highly significant with the DPH probe but only approached statistical significance for the TMA-DPH probe. Although several assumptions have been made in these calculations, it would appear that membrane microviscosity changes in the presence of volatile anaesthetic agents simply reflect the presence of anaesthetic molecules in the lipid membrane and are unrelated to the mechanism of anaesthesia.
In conclusion, our results are inconsistent with a role for perturbation in membrane microviscosity in the mechanism of anaesthesia of volatile agents. While perturbation of the dynamic properties of the bulk phase of the membrane may be unimportant, the ability of anaesthetic agents to dissolve in membrane bilayers may still prove to be important in their action.
